Unlike traditional inflammatory markers such as C-reactive protein (CRP) or procalcitonin (PCT), PSP appears to reflect early immune activation and cellular stress even before clinical symptoms or organ dysfunction emerge. The gene discussed is CRP; the disease is supranuclear palsy, progressive, 1.